"If as the company, specifically Jim Donnelly,
senior vice president of CURA sales and marketing, has already said to expect hundreds of thousands of CURA B2B users next year at brand name companies and organizations, a media blitz is an unnecessary cost in my opinion. The direct sales method appears to be very effective, since the company has indicated to expect substantial results from it. A media blitz would only cause more dilutive equity for the current shareholder, thereby hurting the current shareholders.
I am not a marketing expert but the company's expert, Jim Donnelly, already affirmed an expectation -- hundreds of thousands B2B users -- based solely upon the current B2B pilots. He was specifically and exclusively talking B2B pilots. So if hundreds of thousands are expected based upon current pilots, is it unreasonable to extrapolate millions of B2B users from the same direct sales method going forward?"
Oakie
“Never argue with an idiot. They will only bring you down to their level and beat you with experience.”
